Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?
Is physical exercise a multiple sclerosis disease modifying treatment?
Effects of chlorogenic acid on adenine nucleotides hydrolyzing enzyme activities and expression in platelets of rats experimentally demyelinated with ethidium bromide.
Findings of Optical Coherence Tomography of Retinal Nerve Fiber Layer in Two Common Types of Multiple Sclerosis.
Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica.
MEG evaluation of pico-Tesla external TMS on multiple sclerosis patients.
Author Response.
Therapeutic Application of Monoclonal Antibodies in Multiple Sclerosis.
Myelin contrast across lamina at 7T, ex-vivo and in-vivo dataset.
Economic Impact of Integrated Care Models for Patients with Chronic Diseases: A Systematic Review.
SCT: Spinal Cord Toolbox, an open-source software for processing spinal cord MRI data.
Puerarin Protects Against β-Amyloid-Induced Microglia Apoptosis Via a PI3K-Dependent Signaling Pathway.
[Sjögren's syndrome (SS), a review of the subject and saliva as a diagnostic method].
What you get from what you see: Parametric assessment of visual processing capacity in multiple sclerosis and its relation to cognitive fatigue.
Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany, Hungary and Poland.
Fulminant neuromyelitis optica in a Finnish woman - a case report.
Remyelination researchers regroup after proof-of-concept setback in multiple sclerosis.
Diffusion tensor imaging of occult injury of optic radiation following optic neuritis in multiple sclerosis.
Leptin inhibitors from fungal endophytes (LIFEs): Will be novel therapeutic drugs for obesity and its associated immune mediated diseases.
Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis.
Effect of Laminin on Neurotrophic Factors Expression in Schwann-Like Cells Induced from Human Adipose-Derived Stem Cells In Vitro.
Predicting the Response to Intravenous Immunoglobulins in an Animal Model of Chronic Neuritis.
Performance of F2 B6x129 hybrid mice in the Morris water maze, latent inhibition and prepulse inhibition paradigms: Comparison with C57Bl/6J and 129sv inbred mice.
Meta-Analysis of Differential Connectivity in Gene Co-Expression Networks in Multiple Sclerosis.
Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: Yes.
Pages
« first
‹ previous
…
752
753
754
755
756
757
758
759
760
…
next ›
last »